Confidence: 90%
B0D75VX5ML
View on Amazon →SuppScoreLab compares supplement products for informational purposes. We do not sell products directly, and some links may take you to third-party retailers.
Decision summary
Not a strong option overall. The product is materially held back by weaker dosing.
Best for
Buyers comparing price and availability and okay with a middle-of-the-pack option.
Consider another option if
You prefer fully transparent formulas over blends and ambiguous labeling.
Score breakdown
Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.
Dosage quality
2.4/10Dosing looks weaker than ideal
Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).
Explore next
Chromium: high-bioavailability form declared (Chromium Picolinate). The main limitation is that proprietary blend prevents independent dose verification.
Strengths
Weaknesses
Final verdict
Not a strong option overall. The product is materially held back by weaker dosing.
A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.
ℹ At the minimum effective range, but below the optimal dose with moderate supporting evidence
Dose meets the minimum effective range, but is below the optimal dose used for stronger effects. This is a limiting factor: Dose is below the ranges usually used for stronger effects. The declared form supports strong absorption.
Scientific evidence
Balk et al. systematic review chromium picolinate and glycemic control
Diabetes Technology & Therapeutics • 2007
PMID: 17519436.0
⚠ Dose is below commonly used clinical ranges
Dose is below the minimum effective threshold. This is a limiting factor: Dose is likely below clinically useful levels.
Clinical dosing guidance
Based on established dosing ranges used in clinical practice.
⚠ Limited evidence exists, and dose is below effective threshold
Dose is below the minimum effective threshold. This is a limiting factor: Dose is likely below clinically useful levels. The declared form is acceptable, but not among the best-absorbed options.
Scientific evidence
Fuangchan et al. meta-analysis bitter melon and type 2 diabetes
Journal of Ethnopharmacology • 2011
PMID: 23777923.0
Evidence inferred from established knowledge, not directly linked studies
Supports the formula, but not a major driver: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Important label or formulation details that may affect how this product should be interpreted.
Proprietary blend limits dose transparency
Exact ingredient amounts cannot be verified clearly.
Ceylon Cinnamon dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Formula design looks less coherent than stronger alternatives
The formulation appears less focused than better-built options.
Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.
View methodology →This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.
See the best Berberine supplements ranked with the same methodology, or keep exploring the database.
